Intrinsiqs

Is Oncolytics Biotech Inc. overvalued?

Oncolytics Biotech Inc. (ONCY) — key valuation metrics and fundamentals.

No verdict
Price
$0.37
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$37.1M
Dividend yield
0.0%
Return on equity
1020.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ONCY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.